Skip to main content

Table 9 Change from Baseline in Triglycerides and Total Cholesterol

From: Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

PLO

0.98 [− 10.48, 12.47]

1.35 [− 1.27, 6.50]

1.85 [− 1.88, 8.64]

11.10 [− 2.75, 24.86]

− 3.05 [− 15.37, 9.55]

0.50 [−5.64, 6.60]

ARI

0.37 [− 11.45, 12.83]

0.87 [− 11.26, 13.80]

10.12 [−7.63, 28.42]

−4.03 [− 21.02, 12.83]

− 2.05 [− 5.90, 1.67]

− 2.55 [−9.87, 4.56]

CAR

0.50 [− 5.46, 6.84]

9.75 [− 4.84, 24.02]

− 4.40 [− 17.54, 8.47]

7.06 [2.47, 12.00]

6.55 [− 1.05, 14.47]

9.11 [3.22, 15.46]

OLA

9.25 [− 5.75, 23.54]

− 4.89 [− 18.60, 8.37]

0.50 [− 4.86, 5.88]

0.00 [−8.13, 8.18]

2.55 [− 3.96, 9.20]

−6.55 [− 13.85, 0.46]

QUE

− 14.15 [− 32.40, 4.08]

1.72 [−6.56, 9.94]

1.22 [− 9.02, 11.51]

3.77 [−5.24, 12.88]

− 5.34 [− 14.99, 4.03]

1.21 [− 8.64, 10.98]

LUR

  1. Note: Triglycerides results are on the top-right and Total Cholesterol results are on the bottom-left. Numbers represent the mean change [95% credible interval]. In the top-right comparisons, the row treatment is the reference category. In the bottom-left, the column treatment is the reference category
  2. Abbreviations: PLO Placebo, ARI Aripiprazole, CAR Cariprazine, LUR Lurasidone, OLA Olanzapine, QUE Quetiapine